Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mixing Is Dispensable for Optical Density-Based High-Throughput Growth Screening Assay in Fission Yeast.

International journal of molecular sciences·2026

Same author

Exact and Asymptotic Counts of Binary Phylogenetic Networks with a Few Reticulation Events.

Journal of computational biology : a journal of computational molecular cell biology·2026

Same author

Enhancing k<sub>cat</sub> prediction through residue-aware attention mechanism and pre-trained representations.

Communications biology·2026

Same author

On the Size of the Neighborhoods of a Word.

IEEE transactions on computational biology and bioinformatics·2025

Same author

DSA-DeepFM: a dual-stage attention-enhanced DeepFM model for predicting anticancer synergistic drug combinations.

Bioinformatics advances·2025

Same author

Simple k-RF Metrics for Comparison of Labeled DAGs.

IEEE transactions on computational biology and bioinformatics·2025

Search research articles

Related Experiment Video

Updated: Feb 25, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.

Lin Wang¹, Xiaozhong Li², Louxin Zhang³

¹School of Computer Science and Information Engineering, Tianjin University of Science and Technology, Tianjin, 300457, China. linwang@tust.edu.cn.

|August 4, 2017

Summary

This study introduces a novel method for predicting anticancer drug responses in cell lines, improving precision medicine. The similarity-regularized matrix factorization (SRMF) accurately predicts drug sensitivity and aids in identifying new drug-cancer gene associations.

Keywords:

Anticancer drug response prediction Drug repositioning Matrix factorization Precision cancer medicines

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Experiment Videos

Last Updated: Feb 25, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Area of Science:

Bioinformatics
Computational Biology
Genomics

Background:

Human cancer cell lines are crucial for cancer research and drug development.
Genomic and pharmacologic data from large cell line panels enable precision medicine.
Accurate prediction of drug responses remains a significant challenge.

Purpose of the Study:

To develop an accurate method for predicting anticancer drug responses using cell line genomic data and drug chemical structures.
To leverage pharmacogenomics data for enhanced precision cancer therapy development.

Main Methods:

A similarity-regularized matrix factorization (SRMF) approach was employed.
Drug chemical structure similarity and cell line gene expression similarity were used as regularization terms.
The SRMF model was applied to drug response matrix factorization.

Main Results:

SRMF demonstrated superior performance over existing methods on simulation and real-world datasets (GDSC, CCLE).
The method accurately predicted drug-cancer gene associations, including novel ones.
SRMF facilitated drug repositioning, identifying rapamycin sensitivity in non-small cell lung cancer.

Conclusions:

The proposed data integration method enhances the accuracy of anticancer drug response prediction.
SRMF identifies consistent and novel drug-cancer gene associations.
The method supports drug repositioning and personalized cancer treatment strategies.